Acute and long-term estradiol kinetics in smoking postmenopausal women

References

• Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J. Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000;95:726–31
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004;291:1238–45
   PubMed Web of Science ®Google Scholar
• Tankó LB, Christiansen C. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause 2004;11:104–9
   PubMed Web of Science ®Google Scholar
• Szulc P, Garnero P, Claustrat B, Marchand F, Duboeuf F, Delmas PD. Increased bone resorption in moderate smokers with low body weight: The Minos study. J Clin Endocrinol Metab 2002;87:666–74
   PubMed Web of Science ®Google Scholar
• Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001;68: 259–70
   PubMed Web of Science ®Google Scholar
• Cassidenti DL, Vijod AG, Vijod MA, Stanczyk FZ, Lobo RA. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1990;163:1953–60
   PubMed Web of Science ®Google Scholar
• Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985;313:973–5
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 2000;85:590–6
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Jørgensen C, Kremmer H, Alexandersen P, Christiansen C. Smoking reduces breast tenderness during oral hormone replacement therapy. Climacteric 2004;7:390–6
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Jørgensen HL, Byrjalsen I, Alexandersen P, Christiansen C. The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy. Climacteric 2007;10:480–90
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Byrjalsen I, Jørgensen HL, Christiansen C. The influence of smoking on uterine bleeding during sequential oral hormone therapy. Climacteric 2007;10:147–54
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Nielsen TF, Jorgensen HL, Christiansen C. The influence of smoking on bone loss and response to nasal estradiol. Climacteric 2009;12:59–65
   PubMed Web of Science ®Google Scholar
• Jensen J, Christiansen C. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement. Am J Obstet Gynecol 1988;159:820–5
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Byrjalsen I, Hassager C, Haarbo J, Christiansen C. Low dose estradiol in combination with gestodene to prevent early postmenopausal bone loss. Am J Obstet Gynecol 2000; 183:550–60
   PubMed Web of Science ®Google Scholar
• Warming L, Ravn P, Spielman D, Delmas P, Christiansen C. Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women. Menopause 2004;11:337–42
   PubMed Web of Science ®Google Scholar
• Andersen FS, Transbol I, Christiansen C. Is cigarette smoking a promoter of the menopause? Acta Med Scand 1982;212:137–9
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Shaw PM, Guengerich FP, Shimada T. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 1998; 11:659–65
   PubMed Web of Science ®Google Scholar
• Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 1986;3151:1305–9
   Google Scholar
• Geisler J, Omsjø H, Helle SI, Ekse D, Silsand T, Lønning PE. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. J Endocrinol 1999;162:265–70
   PubMed Web of Science ®Google Scholar
• Bjarnason NH. Drug metabolism and variability. N Engl J Med 2005;353:955–6
   PubMed Web of Science ®Google Scholar
• Komulainen M, Kroger H, Tuppurainen MT, Heikkinen AM, Honkanen R, Saarikoski S. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial. Osteoporos Int 2000;11:211–18
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Alexandersen P, Christiansen C. Number of years since menopause: spontaneous bone loss is dependent, but response to HRT is independent. Bone 2002;30:637–42
   PubMed Web of Science ®Google Scholar
• Ravn P, Cizza G, Bjarnason NH, . for the Early Postmenopausal Intervention Cohort (EPIC) study group. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 1999;14:1622–7
   PubMed Web of Science ®Google Scholar